Measles Epidemics in Romania: Lessons for Public Health and Future Policy.
Romania
epidemic
measles
outbreak
public health
vaccination
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
02
2019
accepted:
08
04
2019
entrez:
11
5
2019
pubmed:
11
5
2019
medline:
11
5
2019
Statut:
epublish
Résumé
Measles is a highly infectious viral disease that continues to be a challenge for many countries worldwide. Although significant improvements have been observed since the introduction of vaccines, measles remains endemic in Romania. Contributing factors include vaccine hesitancy, difficulties in delivering doses to the population, and even the lack of sufficient vaccine supplies. These problems are further exacerbated by an inadequate implementation of public health measures, ranging from inefficient communication programs to the absence of a legislative framework concerning immunization. Moreover, many of the recent outbreaks were associated with chains of transmission in other countries, thus making the control of measles in Romania relevant at an international level. As many difficulties exist, understanding the key factors that limit the success of public health programs may provide guidance in shaping future strategies. Because similar issues are being faced in various other countries, the management of measles in Romania offers valuable lessons for researchers and policy-makers alike.
Identifiants
pubmed: 31073518
doi: 10.3389/fpubh.2019.00098
pmc: PMC6496956
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
98Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M011224/1
Pays : United Kingdom
Références
Lancet. 2006 Feb 4;367(9508):436-42
pubmed: 16458770
N Engl J Med. 2006 Aug 3;355(5):447-55
pubmed: 16885548
Vaccine. 2007 May 16;25(20):3996-4002
pubmed: 17395344
Emerg Infect Dis. 2008 Jan;14(1):107-14
pubmed: 18258089
Soc Sci Med. 2008 Nov;67(9):1382-90
pubmed: 18703263
J Infect Dis. 2011 Jul;204 Suppl 1:S335-42
pubmed: 21666182
J Infect Dis. 2011 Jul;204 Suppl 1:S514-23
pubmed: 21666208
Hum Vaccin Immunother. 2013 Mar;9(3):675-80
pubmed: 23303107
Vaccine. 2013 Apr 18;31 Suppl 2:B5-31
pubmed: 23734366
Euro Surveill. 2013 Dec 12;18(50):20658
pubmed: 24342518
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Euro Surveill. 2016;21(13):null
pubmed: 27074646
Euro Surveill. 2016 May 19;21(20):
pubmed: 27240004
Euro Surveill. 2017 Apr 27;22(17):null
pubmed: 28488998
Euro Surveill. 2017 Jun 8;22(23):null
pubmed: 28661392
Euro Surveill. 2017 Sep 7;22(36):null
pubmed: 28920573
Euro Surveill. 2017 Sep 14;22(37):null
pubmed: 28933342
Euro Surveill. 2017 Oct;22(42):null
pubmed: 29067903
Epidemiol Infect. 2018 Oct;146(13):1692-1698
pubmed: 30086813
Euro Surveill. 2018 Aug;23(31):null
pubmed: 30086818
J Infect Dis. 1994 Nov;170 Suppl 1:S32-41
pubmed: 7930752